Scarica l'app Stockscreener
81.06
3.05%
-2.55
Dopo l'orario di chiusura:
81.85
0.79
+0.97%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$83.61
Aprire:
$84.46
Volume 24 ore:
2.69M
Relative Volume:
1.51
Capitalizzazione di mercato:
$14.67B
Reddito:
$342.96M
Utile/perdita netta:
$-864.29M
Rapporto P/E:
-14.61
EPS:
-5.55
Flusso di cassa netto:
$-636.03M
1 W Prestazione:
+2.21%
1M Prestazione:
+5.62%
6M Prestazione:
+5.26%
1 anno Prestazione:
+187.04%
Intervallo 1D:
$80.43
$84.91
Intervallo di 1 settimana:
$78.75
$84.91
Portata 52W:
$21.92
$84.91
Insmed Inc Stock (INSM) Company Profile
Nome
Insmed Inc
Settore
Industria
Telefono
908-977-9900
Indirizzo
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Confronta INSM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
81.06 | 14.67B | 342.96M | -864.29M | -636.03M | -5.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-23 | Iniziato | Truist | Buy |
| 2024-02-15 | Iniziato | Wolfe Research | Outperform |
| 2023-12-08 | Iniziato | Wells Fargo | Overweight |
| 2023-11-20 | Ripresa | JP Morgan | Overweight |
| 2023-07-26 | Iniziato | Guggenheim | Buy |
| 2022-12-09 | Iniziato | Mizuho | Buy |
| 2022-12-07 | Iniziato | Barclays | Overweight |
| 2022-11-18 | Iniziato | BofA Securities | Buy |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2021-12-06 | Iniziato | JP Morgan | Overweight |
| 2021-10-19 | Ripresa | Monness Crespi & Hardt | Buy |
| 2021-10-19 | Ripresa | Morgan Stanley | Overweight |
| 2021-10-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2020-12-17 | Iniziato | Berenberg | Buy |
| 2020-10-12 | Ripresa | Stifel | Buy |
| 2019-09-03 | Iniziato | Goldman | Buy |
| 2019-04-09 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-15 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-01-02 | Iniziato | Canaccord Genuity | Buy |
| 2018-08-06 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | Iniziato | Goldman | Neutral |
| 2018-04-23 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | Iniziato | Morgan Stanley | Overweight |
| 2018-01-18 | Iniziato | Credit Suisse | Neutral |
| 2017-09-05 | Reiterato | Evercore ISI | Outperform |
| 2017-08-17 | Iniziato | Evercore ISI | Outperform |
| 2017-07-11 | Iniziato | Robert W. Baird | Outperform |
| 2016-03-15 | Iniziato | Stifel | Buy |
| 2015-11-09 | Downgrade | UBS | Buy → Neutral |
| 2015-10-06 | Reiterato | H.C. Wainwright | Buy |
| 2015-06-09 | Iniziato | Citigroup | Neutral |
| 2014-03-26 | Reiterato | HC Wainwright | Buy |
Mostra tutto
Insmed Inc Borsa (INSM) Ultime notizie
Insmed (NASDAQ:INSM) Shares Gap Down on Disappointing Earnings - MarketBeat
UBS Adjusts Insmed Price Target to $105 From $84, Maintains Buy Rating -February 21, 2025 at 10:46 am EST - Marketscreener.com
UBS raises Insmed stock target to $105, maintains buy rating - Investing.com
Decoding Insmed Inc (INSM): A Strategic SWOT Insight - GuruFocus.com
Insmed's Q4 Loss Wider Than Expected, Sales In Line With Estimates - Yahoo Finance
Insmed Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Insmed Incorporated (NASDAQ:INSM) Q4 2024 Earnings Call Transcript - Insider Monkey
Peregrine Capital Management LLC Increases Stock Holdings in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed: Q4 Earnings Snapshot - CTPost
Insmed Incorporated (NASDAQ:INSM) Position Increased by Rhumbline Advisers - MarketBeat
Insmed Inc (INSM) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance
Insmed CEO William Lewis sells $2.07 million in stock By Investing.com - Investing.com Nigeria
Insmed CEO William Lewis sells $2.07 million in stock - Investing.com India
State of New Jersey Common Pension Fund D Buys 4,438 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Insmed’s Q4 2024 results miss EPS forecast By Investing.com - Investing.com Nigeria
Cantor Fitzgerald Reaffirms "Overweight" Rating for Insmed (NASDAQ:INSM) - MarketBeat
Earnings call transcript: Insmed's Q4 2024 results miss EPS forecast - Investing.com
Insmed falls on weak 2025 sales forecast for lead drug - TradingView
Insmed (NASDAQ:INSM) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
Insmed (INSM) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Insmed (INSM) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
INSMED Earnings Results: $INSM Reports Quarterly Earnings - Nasdaq
Insmed earnings missed by $0.14, revenue topped estimates - Investing.com
Earnings Flash (INSM) Insmed Posts Q4 Net Revenue $104.4M, vs. FactSet Est of $102.1M - Marketscreener.com
INSMED Inc SEC 10-K Report - TradingView
Insmed Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides Business Update - Marketscreener.com
Insmed's chief medical officer sells $2.97 million in stock - MSN
Insmed Incorporated (NASDAQ:INSM) Shares Bought by Allspring Global Investments Holdings LLC - MarketBeat
Insmed (INSM) to Release Earnings on Thursday - MarketBeat
Insmed (NASDAQ:INSM) Hits New 52-Week HighShould You Buy? - MarketBeat
Van ECK Associates Corp Trims Position in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed stock soars to 52-week high, hits $82.08 - Investing.com India
Will Insmed Incorporated’s (INSM) New Drugs be Able to Peak Sales? - Yahoo Finance UK
TimesSquare Capital Management LLC Grows Position in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Principal Financial Group Inc. Has $125.49 Million Position in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Mizuho raises Insmed stock price target to $96 from $88 By Investing.com - Investing.com Canada
Rice Hall James & Associates LLC Sells 4,632 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Will These 5 Biotech Stocks Surpass Q4 Earnings Forecast? - MSN
Fiera Capital Corp Has $40.17 Million Stock Holdings in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Countdown to Insmed (INSM) Q4 Earnings: Wall Street Forecasts for Key Metrics - MSN
Insider Selling: Insmed Incorporated (NASDAQ:INSM) CFO Sells 13,302 Shares of Stock - MarketBeat
Insmed Incorporated (NASDAQ:INSM) COO Sells $3,378,264.75 in Stock - MarketBeat
Martina M.D. Flammer Sells 37,828 Shares of Insmed Incorporated (NASDAQ:INSM) Stock - MarketBeat
Insider Sell: Sara Bonstein Sells 18,321 Shares of Insmed Inc (I - GuruFocus.com
Here's How Much $100 Invested In Insmed 10 Years Ago Would Be Worth Today - Benzinga
Peering Into Insmed's Recent Short Interest - Benzinga
Financial Advocates Investment Management Takes Position in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
WCM Investment Management LLC Cuts Stake in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed Inc Azioni (INSM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.27%
1.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):